| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
46945.0 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
56234.1 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
166670.0 |
nM |
None |
| Betapolyomavirus hominis |
BK polyomavirus |
EC50 |
700.0 |
nM |
10.1128/aac.01241-07 |
| Chlorocebus sabaeus |
Vero |
CC50 |
22560.0 |
nM |
10.1021/jm960289o |
| Chlorocebus sabaeus |
Vero |
EC50 |
870.0 |
nM |
10.1021/jm960289o |
| Chlorocebus sabaeus |
Vero |
EC50 |
1150.0 |
nM |
10.1021/jm960289o |
| Chlorocebus sabaeus |
Vero |
IC50 |
600.0 |
nM |
10.1021/jm00038a015 |
| Cowpox virus |
Cowpox virus |
IC50 |
13000.0 |
nM |
10.1016/j.bmc.2008.11.075 |
| Duck hepatitis B virus |
Duck hepatitis B virus |
Activity |
0.8 |
g |
10.1007/s00044-011-9616-2 |
| Duck hepatitis B virus |
Duck hepatitis B virus |
Activity |
nan |
None |
10.1007/s00044-011-9616-2 |
| Duck hepatitis B virus |
Duck hepatitis B virus |
Inhibition |
nan |
% |
10.1007/s00044-011-9616-2 |
| Hepatitis B virus |
Hepatitis B virus |
Activity |
-5.7 |
log10CFU/ml |
10.1128/aac.00467-07 |
| Hepatitis B virus |
Hepatitis B virus |
Activity |
35.0 |
IU/ml |
10.1128/aac.00467-07 |
| Hepatitis B virus |
Hepatitis B virus |
Activity |
nan |
None |
10.1007/s00044-011-9616-2 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
830.0 |
nM |
10.1016/j.ejmech.2013.02.039 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
960.0 |
nM |
10.1016/j.ejmech.2012.01.013 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
1500.0 |
nM |
10.1016/j.bmcl.2010.01.010 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
1500.0 |
nM |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
1800.0 |
nM |
10.1016/j.bmcl.2010.01.010 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
2000.0 |
nM |
10.1016/j.bmcl.2010.01.010 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
2000.0 |
nM |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
2100.0 |
nM |
10.1016/j.bmcl.2010.01.010 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
2200.0 |
nM |
10.1016/j.bmcl.2010.01.010 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
2400.0 |
nM |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
2500.0 |
nM |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
2600.0 |
nM |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
3090.0 |
nM |
10.1016/j.bmc.2019.07.012 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
7500.0 |
nM |
10.1016/j.bmcl.2010.01.010 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
9800.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
10000.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
13000.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
13600.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
14000.0 |
nM |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
15000.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
15500.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
15800.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
27000.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
40000.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
48000.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
50300.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
77000.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
100000.0 |
nM |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
7.0 |
uM |
10.1016/j.bmcl.2010.01.010 |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
7.0 |
uM |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
7.2 |
uM |
10.1016/j.bmcl.2010.01.010 |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
7.2 |
uM |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
7.3 |
uM |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
7.6 |
uM |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
8.0 |
uM |
10.1016/j.bmcl.2010.01.010 |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
8.0 |
uM |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
8.2 |
uM |
10.1016/j.bmcl.2010.01.010 |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
8.3 |
uM |
10.1016/j.bmcl.2010.01.010 |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
29.0 |
uM |
10.1016/j.bmcl.2010.01.010 |
| Hepatitis B virus |
Hepatitis B virus |
EC90 |
52.0 |
uM |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
ED50 |
0.2 |
umol.kg-1 |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
ED90 |
3.6 |
umol/Kg |
10.1128/aac.00114-09 |
| Hepatitis B virus |
Hepatitis B virus |
IC50 |
330.0 |
nM |
10.1016/j.bmcl.2009.10.072 |
| Hepatitis B virus |
Hepatitis B virus |
IC50 |
480.0 |
nM |
10.1007/s00044-011-9616-2 |
| Hepatitis B virus |
Hepatitis B virus |
IC50 |
580.0 |
nM |
10.1007/s00044-011-9616-2 |
| Hepatitis B virus |
Hepatitis B virus |
Inhibition |
nan |
% |
10.1007/s00044-011-9616-2 |
| Hepatitis B virus |
Hepatitis B virus |
Ratio EC50 |
0.7 |
None |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
Ratio EC50 |
0.98 |
None |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
Ratio EC50 |
1.1 |
None |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
Ratio EC50 |
2.7 |
None |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
Ratio EC50 |
3.2 |
None |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
Ratio EC50 |
4.0 |
None |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
Ratio EC50 |
4.8 |
None |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
Ratio EC50 |
6.3 |
None |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
Ratio EC50 |
7.7 |
None |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
Ratio EC50 |
10.0 |
None |
10.1128/aac.01440-06 |
| Hepatitis B virus |
Hepatitis B virus |
Ratio EC50 |
15.0 |
None |
10.1128/aac.01440-06 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile acid transporter |
Activity |
nan |
None |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
Bile acid transporter |
Km |
nan |
None |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
Bile acid transporter |
Vmax |
nan |
None |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
Bile acid transporter |
Vmax/Km |
nan |
None |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
Bile salt export pump |
IC50 |
46000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
CCRF-CEM |
CC50 |
740.0 |
nM |
10.1021/jm050641a |
| Homo sapiens |
CCRF-CEM |
CC50 |
1600.0 |
nM |
10.1016/j.ejmech.2013.02.039 |
| Homo sapiens |
CCRF-CEM |
T1/2 |
11.0 |
hr |
10.1016/j.ejmech.2013.02.039 |
| Homo sapiens |
CEM-SS |
CC50 |
4400.0 |
nM |
10.1021/jm960289o |
| Homo sapiens |
CEM-SS |
EC50 |
40.0 |
nM |
10.1021/jm960289o |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HEK293 |
Activity |
47.16 |
% |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
HEL |
MCC |
50000.0 |
nM |
10.1016/j.ejmech.2013.02.039 |
| Homo sapiens |
HepG2 |
Activity |
nan |
None |
10.1007/s00044-011-9616-2 |
| Homo sapiens |
HepG2 2.2.15 |
CC50 |
438920.0 |
nM |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-4.89 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
18.04 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
HK-2 |
Activity |
16.8 |
% |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
HK-2 |
Activity |
18.9 |
% |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
HK-2 |
Activity |
43.3 |
% |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
HK-2 |
Activity |
61.01 |
% |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
HK-2 |
Activity |
nan |
None |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
Homo sapiens |
Activity |
15.0 |
% |
10.1128/aac.00467-07 |
| Homo sapiens |
Homo sapiens |
Activity |
nan |
None |
10.1128/aac.00467-07 |
| Homo sapiens |
Homo sapiens |
AUC |
383.63 |
ng.hr.mL-1 |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
Css |
0.032 |
uM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
Rate of hydrolysis |
2.4 |
None |
10.1021/jm960289o |
| Homo sapiens |
Homo sapiens |
Rate of hydrolysis |
5.0 |
None |
10.1021/jm960289o |
| Homo sapiens |
Huh-7 |
CC50 |
25000.0 |
nM |
10.1016/j.ejmech.2013.02.039 |
| Homo sapiens |
Huh-7 |
T1/2 |
11.0 |
hr |
10.1016/j.ejmech.2013.02.039 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Liver microsomes |
T1/2 |
0.75 |
hr |
10.1016/j.bmcl.2009.10.072 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
MRC5 |
CC50 |
15700.0 |
nM |
10.1021/jm960289o |
| Homo sapiens |
MRC5 |
EC50 |
910.0 |
nM |
10.1021/jm960289o |
| Homo sapiens |
MRC5 |
EC50 |
1230.0 |
nM |
10.1021/jm960289o |
| Homo sapiens |
MT4 |
CC50 |
740.0 |
nM |
10.1021/jm960289o |
| Homo sapiens |
MT4 |
EC50 |
80.0 |
nM |
10.1021/jm960289o |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
PBMC |
Activity |
18.0 |
None |
10.1128/aac.00467-07 |
| Homo sapiens |
PBMC |
Activity |
26.3 |
None |
10.1128/aac.00467-07 |
| Homo sapiens |
PBMC |
Activity |
51.0 |
pg/ml |
10.1128/aac.00467-07 |
| Homo sapiens |
PBMC |
Activity |
58.9 |
None |
10.1128/aac.00467-07 |
| Homo sapiens |
PBMC |
Activity |
61.5 |
None |
10.1128/aac.00467-07 |
| Homo sapiens |
PBMC |
Activity |
63.9 |
None |
10.1128/aac.00467-07 |
| Homo sapiens |
PBMC |
Activity |
184.3 |
None |
10.1128/aac.00467-07 |
| Homo sapiens |
PBMC |
Activity |
nan |
None |
10.1128/aac.00467-07 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Activity |
400.0 |
pmol/min/mg |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
Solute carrier family 22 member 6 |
IC50 |
13500.0 |
nM |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
EC50 |
200.0 |
nM |
10.1016/j.ejmech.2013.02.039 |
| Human alphaherpesvirus 2 |
Human alphaherpesvirus 2 |
EC50 |
200.0 |
nM |
10.1016/j.ejmech.2013.02.039 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
45.0 |
nM |
10.1016/j.ejmech.2013.02.039 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
180.0 |
nM |
10.1021/jm050641a |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
62.0 |
nM |
10.1016/j.ejmech.2013.02.039 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
75.0 |
nM |
10.1021/jm050641a |
| Marmota monax |
Marmota monax |
Activity |
nan |
None |
10.1128/aac.00654-08 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
37300.0 |
nM |
10.1021/acs.jmedchem.9b00182 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
6745.6 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
15101.4 |
nM |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Intestine |
Selectivity index |
0.08 |
None |
10.1021/jm7012216 |
| Rattus norvegicus |
Kidney |
Drug uptake |
742.0 |
nmol.hr/g |
10.1021/jm7012216 |
| Rattus norvegicus |
Liver |
Drug uptake |
284.0 |
nmol.hr/g |
10.1021/jm7012216 |
| Rattus norvegicus |
Liver |
Selectivity index |
0.4 |
None |
10.1021/jm7012216 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
28695.4 |
nM |
None |
| Rattus norvegicus |
Plasma |
Drug uptake |
34.0 |
nmol.hr/g |
10.1021/jm7012216 |
| Rattus norvegicus |
Plasma |
T1/2 |
0.75 |
hr |
10.1016/j.bmcl.2009.10.072 |
| Rattus norvegicus |
Rattus norvegicus |
Drug uptake |
3206.0 |
nmol.hr/g |
10.1021/jm7012216 |
| Rattus norvegicus |
Rattus norvegicus |
T1/2 |
0.52 |
hr |
10.1016/j.ejmech.2012.01.013 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-0.4186 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
30.75 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1661 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-3.56 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.24 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.49 |
% |
10.6019/CHEMBL4495565 |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
25118.9 |
nM |
None |
| Trypanosoma brucei brucei (strain 927/4 GUTat10.1) |
Putative uncharacterized protein |
Potency |
35481.3 |
nM |
None |
| Vaccinia virus |
Vaccinia virus |
EC50 |
4000.0 |
nM |
10.1016/j.ejmech.2013.02.039 |
| Vaccinia virus |
Vaccinia virus |
IC50 |
5100.0 |
nM |
10.1016/j.bmc.2008.11.075 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
1.0 |
% |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
1.8 |
None |
10.1128/aac.00325-07 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
2.0 |
% |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
2.5 |
None |
10.1128/aac.00325-07 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
4.1 |
log10ng/ml |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
4.3 |
log10ng/ml |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
4.8 |
log10ng/ml |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
5.0 |
% |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
5.0 |
log10ng/ml |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
13.0 |
% |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
21.0 |
% |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
24.0 |
pg |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
33.0 |
pg |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
34.0 |
pg |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
45.0 |
% |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
46.0 |
pg |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
48.0 |
% |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
151.0 |
pg |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
324.0 |
pg |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
330.0 |
pg |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
1147.0 |
pg |
10.1128/aac.00654-08 |
| Woodchuck hepatitis virus |
Woodchuck hepatitis virus |
Activity |
nan |
None |
10.1128/aac.00654-08 |
| None |
ADMET |
Activity |
42.32 |
% |
10.1016/j.ejmech.2012.01.013 |
| None |
ADMET |
Activity |
47.49 |
% |
10.1016/j.ejmech.2012.01.013 |
| None |
ADMET |
Activity |
50.02 |
% |
10.1016/j.ejmech.2012.01.013 |
| None |
ADMET |
AUC |
1655.22 |
ng.hr.mL-1 |
10.1016/j.bmc.2019.07.012 |
| None |
ADMET |
CC50 |
3100.0 |
nM |
10.1128/aac.01241-07 |
| None |
ADMET |
CC50 |
365000.0 |
nM |
10.1128/aac.01440-06 |
| None |
ADMET |
CC50 |
471100.0 |
nM |
10.1016/j.ejmech.2012.01.013 |
| None |
ADMET |
CC50 |
488050.0 |
nM |
10.1016/j.ejmech.2012.01.013 |
| None |
ADMET |
CC50 |
555000.0 |
nM |
10.1016/j.bmcl.2009.10.072 |
| None |
ADMET |
CL |
60.4 |
L/hr |
10.1016/j.bmc.2019.07.012 |
| None |
ADMET |
Cmax |
1222561.22 |
nM |
10.1016/j.bmc.2019.07.012 |
| None |
ADMET |
Drug metabolism |
nan |
None |
10.1016/j.ejmech.2013.02.039 |
| None |
ADMET |
Drug uptake |
50.73 |
micromol/min |
10.1016/j.bmc.2019.07.012 |
| None |
ADMET |
Drug uptake |
nan |
None |
10.1016/j.bmc.2019.07.012 |
| None |
ADMET |
F |
17.3 |
% |
10.1021/jm00038a015 |
| None |
ADMET |
Kel |
0.395 |
/hr |
10.1016/j.bmc.2019.07.012 |
| None |
ADMET |
MRT |
5.676 |
hr |
10.1016/j.bmc.2019.07.012 |
| None |
ADMET |
Rate of decomposition |
3.7 |
None |
10.1021/jm960289o |
| None |
ADMET |
Rate of decomposition |
32.7 |
None |
10.1021/jm960289o |
| None |
ADMET |
T1/2 |
1.762 |
hr |
10.1016/j.bmc.2019.07.012 |
| None |
ADMET |
T1/2 |
5.0 |
hr |
10.1021/jm960289o |
| None |
ADMET |
T1/2 |
55.0 |
hr |
10.1016/j.ejmech.2013.02.039 |
| None |
ADMET |
Vd |
153.13 |
L.kg-1 |
10.1016/j.bmc.2019.07.012 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NON-PROTEIN TARGET |
CC50 |
400000.0 |
nM |
10.1021/acs.jnatprod.6b00332 |
| None |
NON-PROTEIN TARGET |
IC50 |
270000.0 |
nM |
10.1021/acs.jnatprod.6b00332 |
| None |
NON-PROTEIN TARGET |
IC50 |
290000.0 |
nM |
10.1021/acs.jnatprod.6b00332 |
| None |
NON-PROTEIN TARGET |
Potency |
0.7 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
29.8 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
14950.2 |
nM |
None |
| None |
No relevant target |
Drug degradation |
39.1 |
% |
10.1016/j.ejmech.2012.01.013 |
| None |
No relevant target |
Drug degradation |
42.5 |
% |
10.1016/j.ejmech.2012.01.013 |
| None |
No relevant target |
LogP |
2.48 |
None |
10.1021/jm960289o |
| None |
No relevant target |
Stability |
14.7 |
hr |
10.1021/jm050641a |
| None |
No relevant target |
Stability |
nan |
% |
10.1021/jm050641a |
| None |
No relevant target |
T1/2 |
1.0 |
hr |
10.1016/j.ejmech.2013.02.039 |
| None |
No relevant target |
T1/2 |
7.0 |
hr |
10.1016/j.ejmech.2013.02.039 |
| None |
No relevant target |
T1/2 |
31.0 |
hr |
10.1016/j.ejmech.2013.02.039 |
| None |
No relevant target |
T1/2 |
48.0 |
hr |
10.1016/j.ejmech.2013.02.039 |
| None |
No relevant target |
T1/2 |
72.0 |
hr |
10.1016/j.ejmech.2013.02.039 |
| None |
Unchecked |
Ac50 |
0.631 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.122 |
uM |
None |
| None |
Unchecked |
Ac50 |
11.22 |
uM |
None |
| None |
Unchecked |
Ac50 |
44.67 |
uM |
None |
| None |
Unchecked |
AC50 |
631.0 |
nM |
None |
| None |
Unchecked |
AC50 |
1122.0 |
nM |
None |
| None |
Unchecked |
AC50 |
11220.2 |
nM |
None |
| None |
Unchecked |
AC50 |
44670.0 |
nM |
None |
| None |
Unchecked |
IC50 |
60.8 |
nM |
None |
| None |
Unchecked |
IC50 |
134.0 |
nM |
None |
| None |
Unchecked |
IC50 |
387.4 |
nM |
None |
| None |
Unchecked |
IC50 |
391.3 |
nM |
None |
| None |
Unchecked |
IC50 |
704.3 |
nM |
None |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
None |
| None |
Unchecked |
Ratio |
0.00069 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
7.5 |
None |
10.1016/j.bmc.2019.07.012 |
| None |
Unchecked |
Ratio CC50/EC50 |
142.04 |
None |
10.1016/j.bmc.2019.07.012 |
| None |
Unchecked |
Ratio CC50/EC50 |
490.73 |
None |
10.1016/j.ejmech.2012.01.013 |
| None |
Unchecked |
Ratio CC50/IC50 |
1680.0 |
None |
10.1016/j.bmcl.2009.10.072 |
| None |
Unchecked |
Selectivity Index |
5.7 |
None |
10.1128/aac.01241-07 |